• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Neumora Therapeutics, Inc. - Common Stock (NQ: NMRA )

    11.68 +0.18 (+1.57%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Aug 23, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 325,515
    Open 11.50
    Bid (Size) 4.680 (2)
    Ask (Size) 12.69 (1)
    Prev. Close 11.50
    Today's Range 11.40 - 12.02
    52wk Range 8.330 - 21.00
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Neumora Therapeutics to Host Key Opinion Leader Roundtable to Discuss the Potential of Navacaprant in Neuropsychiatric Disorders
    Roundtable discussion to take place on Thursday, September 12 at 8:00 a.m. ET 
    From Neumora Therapeutics, Inc.
    Via GlobeNewswire
    NMRA Stock Earnings: Neumora Therapeutics Meets EPS for Q2 2024
    NMRA stock results show that Neumora Therapeutics met analyst estimates for earnings per share the second quarter of 2024. 
    Via InvestorPlace

    Performance

    YTD
    -30.89%
    -30.89%
    1 Month
    -5.88%
    -5.88%
    3 Month
    +22.82%
    +22.82%
    6 Month
    -37.00%
    -37.00%
    1 Year
    -28.12%
    -28.12%

    More News

    Read More
    Neumora Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
    From Neumora Therapeutics, Inc.
    Via GlobeNewswire
    Neumora Therapeutics Announces Initiation of Phase 1b Study of NMRA-511 for Treatment of Alzheimer’s Disease Agitation
    From Neumora Therapeutics, Inc.
    Via GlobeNewswire
    Neumora Therapeutics Announces Initiation of Phase 2 Study of Navacaprant in Bipolar Depression
    From Neumora Therapeutics, Inc.
    Via GlobeNewswire
    NMRA Stock Earnings: Neumora Therapeutics Meets EPS for Q1 2024
    Via InvestorPlace
    Neumora Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
    From Neumora Therapeutics, Inc.
    Via GlobeNewswire
    Neumora Therapeutics to Participate in Upcoming Conferences in May
    From Neumora Therapeutics, Inc.
    Via GlobeNewswire
    S&P 500 Down Over 1%; US Retail Sales Increase 0.7% In March
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    Crude Oil Down 1%; Charles Schwab Sales Top Estimates
    Via Benzinga
    Topics Stocks
    Exposures Fossil Fuels US Equities
    Why Is Neurology Focused-Neumora Therapeutics Shares Trading Lower On Monday?
    Via Benzinga
    Exposures Product Safety
    Neumora Stock Hits 2024 Low As Side Effects In Rabbits Torpedo Schizophrenia Drug
    Via Investor's Business Daily
    Why Is Mobile Global Esports (MGAM) Stock Down 18% Today?
    Via InvestorPlace
    Why Is Neumora Therapeutics (NMRA) Stock Down 25% Today?
    Via InvestorPlace
    Marinus Pharmaceuticals, Neumora Therapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market Session
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
    Via InvestorPlace
    Neumora Therapeutics Announces Clinical Hold of Phase 1 NMRA-266 Study
    From Neumora Therapeutics, Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    Why Clover Health Investments Shares Are Trading Higher By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    Dollar Tree Reports Weak Earnings, Joins Tesla, Arcos Dorados And Other Big Stocks Moving Lower On Wednesday
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Neumora Therapeutics to Participate at Stifel 2024 Virtual CNS Days
    From Neumora Therapeutics, Inc.
    Via GlobeNewswire
    NMRA Stock Earnings: Neumora Therapeutics Misses EPS for Q4 2023
    Via InvestorPlace
    Neumora Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
    From Neumora Therapeutics, Inc.
    Via GlobeNewswire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.